A new University of Georgia study suggests that rapid detection combined with aggressive education can dramatically curtail outbreaks of emerging infectious disease such as severe acute respiratory syndrome (SARS).
The first human trial of a DNA vaccine designed to prevent H5N1 avian influenza infection began on December 21, 2006, when the vaccine was administered to the first volunteer at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the NIH Institutes, designed the vaccine. The vaccine does not contain any infectious material from the influenza virus.
Cornell researchers studied a virus related to the avian influenza virus to see whether a hypothetical mutated form of H5N1 could infect people through drinking and wastewater systems.
Drawing upon a massive database established with funds from the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), scientists have completed the most comprehensive analysis to date of published influenza A virus epitopes–the critical sites on the virus that are recognized by the immune system.
Researchers from the La Jolla Institute for Allergy & Immunology announced today the results of a first of its kind study analyzing all published data worldwide on influenza A virus antibody and T cell epitopes. Antibody and T cell epitopes are small sites on a virus that are the targets of the immune response, and they are critical for developing therapies and vaccines to combat infectious disease.
The Government Influenza Vaccination Programme for 2006-07 will be extended until the end of February, the Department of Health says. It provides free vaccinations to eight needy and high-risk groups.
The Avian and Human Influenza Facility of the World Bank announced today that six grants with a combined value of US$28 million have been approved to assist some 13 countries in five regions to fight the threat posed by avian and human influenza:
Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health in Bethesda, Md., and colleagues at the University of Virginia in Charlottesville have succeeded in imaging, in unprecedented detail, the virus that causes influenza.
A 26-year-old Egyptian man died of bird flu on Wednesday, the third member of his extended family to die of the virus, a World Health Organisation (WHO) report highlighted.
A 15-year-old girl became the ninth fatal victim of the avian influenza virus and the first minor to lose her life to the disease in Egypt, said health ministry media official Sayyid Al-Abbasi.